Table 2: Univariate analysis of demographic and comorbidities in adult Covid-19 patients at NYU Langone Health from March 3 - May 31 2020 (N = 5473).
Risk Factor |
Male (N = 4036) |
Female (N = 4288) |
Sex p-value |
Old (N = 3372) |
Young (N = 4952) |
Age p-value |
White (N = 3421) |
Black (N = 1455) |
Asian (N = 616) |
Other/Unknown (N = 2832) |
Race p-value |
Age < 60 yo |
2221 (55.0) |
2731 (63.7) |
< 0.001 |
- |
- |
- |
1681 (49.1) |
922 (63.4) |
372 (60.4) |
1977 (69.8) |
< 0.001 |
Female |
- |
- |
- |
1557 (46.2) |
2731 (55.1) |
< 0.001 |
1727 (50.5) |
907 (62.3) |
312 (50.6) |
1342 (47.4) |
< 0.001 |
HIV/AIDS |
50 (1.2) |
7 (0.2) |
< 0.001 |
28 (0.8) |
29 (0.6) |
0.19** |
15 (0.4) |
9 (0.6) |
1 (0.2) |
32 (1.1) |
0.003 |
Alcohol Misuse |
115 (2.9) |
17 (0.4) |
< 0.001 |
43 (1.3) |
89 (1.8) |
0.063** |
40 (1.2) |
21 (1.4) |
4 (0.7) |
67 (2.4) |
< 0.001 |
Asthma |
318 (7.9) |
480 (11.2) |
< 0.001** |
346 (10.3) |
452 (9.1) |
0.084 |
287 (8.4) |
174 (12.0) |
46 (7.5) |
291 (10.3) |
< 0.001** |
Anemia |
201 (5.0) |
231 (5.4) |
0.40 |
267 (7.9) |
165 (3.3) |
< 0.001** |
206 (6.0) |
83 (5.7) |
33 (5.4) |
110 (3.9) |
0.002 |
Morbid Obesity (BMI > = 35) |
520 (12.9) |
740 (17.3) |
0.001 |
440 (13.0) |
820 (16.6) |
< 0.001** |
479 (14.0) |
335 (23.0) |
20 (3.2) |
426 (15.0) |
< 0.001 |
Cardiac Arrhythmia |
1751 (43.4) |
1188 (27.7) |
< 0.001** |
1899 (56.3) |
1040 (21.0) |
< 0.001** |
1352 (39.5) |
469 (32.2) |
210 (34.1) |
908 (32.1) |
< 0.001 |
CHF |
422 (10.5) |
311 (7.3) |
< 0.001** |
612 (18.1) |
121 (2.4) |
< 0.001** |
395 (11.5) |
115 (7.9) |
38 (6.2) |
185 (6.5) |
< 0.001 |
Cerebrovascular Disease |
306 (7.6) |
221 (5.2) |
< 0.001 |
428 (12.7) |
99 (2.0) |
< 0.001** |
260 (7.6) |
93 (6.4) |
33 (5.4) |
141 (5.0) |
< 0.001 |
Coagulopathy |
577 (14.3) |
318 (7.4) |
< 0.001 |
607 (18.0) |
288 (5.8) |
< 0.001** |
505 (14.8) |
140 (9.6) |
81 (13.1) |
314 (11.1) |
< 0.001* |
CPD |
594 (14.7) |
712 (16.6) |
0.018** |
763 (22.6) |
543 (11.0) |
< 0.001 |
590 (17.2) |
242 (16.6) |
77 (12.5) |
397 (14.0) |
< 0.001 |
Cancer |
276 (6.8) |
243 (5.7) |
0.027 |
405 (12.0) |
114 (2.3) |
< 0.001** |
261 (7.6) |
85 (5.8) |
33 (5.4) |
140 (4.9) |
< 0.001** |
Hematologic Malignancy |
36 (0.9) |
15 (0.3) |
< 0.001 |
38 (1.1) |
13 (0.3) |
< 0.001 |
28 (0.8) |
3 (0.2) |
3 (0.5) |
17 (0.6) |
0.09 |
Solid Tumor (without Metastasis) |
214 (5.3) |
202 (4.7) |
0.22 |
329 (9.8) |
87 (1.8) |
< 0.001 |
211 (6.2) |
74 (5.1) |
29 (4.7) |
102 (3.6) |
< 0.001** |
Lymphoma |
34 (0.8) |
32 (0.7) |
0.62* |
50 (1.5) |
16 (0.3) |
< 0.001 |
32 (0.9) |
10 (0.7) |
2 (0.3) |
22 (0.8) |
0.42** |
Dementia |
184 (4.6) |
225 (5.2) |
0.15** |
401 (11.9) |
8 (0.2) |
< 0.001 |
263 (7.7) |
48 (3.3) |
27 (4.4) |
71 (2.5) |
< 0.001* |
Depression |
350 (8.7) |
428 (10.0) |
0.041** |
499 (14.8) |
279 (5.6) |
< 0.001 |
445 (13.0) |
97 (6.7) |
39 (6.3) |
197 (7.0) |
< 0.001 |
Diabetes with Complications |
471 (11.7) |
338 (7.9) |
< 0.001 |
646 (19.2) |
163 (3.3) |
< 0.001** |
333 (9.7) |
173 (11.9) |
53 (8.6) |
250 (8.8) |
0.010 |
Fluid and Electrolyte Disorders |
1749 (43.3) |
1096 (25.6) |
< 0.001 |
1903 (56.4) |
942 (19.0) |
< 0.001** |
1317 (38.5) |
455 (31.3) |
238 (38.6) |
994 (35.1) |
< 0.001** |
HLD |
1468 (36.4) |
1163 (27.1) |
< 0.001** |
1916 (56.8) |
715 (14.4) |
< 0.001** |
1298 (37.9) |
451 (31.0) |
186 (30.2) |
696 (24.6) |
< 0.001 |
HTN |
1949 (48.3) |
1510 (35.2) |
< 0.001** |
2464 (73.1) |
995 (20.1) |
< 0.001** |
1559 (45.6) |
700 (48.1) |
247 (40.1) |
953 (33.7) |
< 0.001 |
Hypothyroidism |
220 (5.5) |
519 (12.1) |
< 0.001 |
507 (15.0) |
232 (4.7) |
< 0.001 |
428 (12.5) |
94 (6.5) |
39 (6.3) |
178 (6.3) |
< 0.001 |
Liver Disease |
278 (6.9) |
155 (3.6) |
< 0.001** |
243 (7.2) |
190 (3.8) |
< 0.001** |
190 (5.6) |
56 (3.8) |
38 (6.2) |
149 (5.3) |
0.059 |
Myocardial Infarction |
350 (8.7) |
188 (4.4) |
< 0.001** |
447 (13.3) |
91 (1.8) |
< 0.001** |
536 (15.7) |
189 (13.0) |
78 (12.7) |
304 (10.7) |
< 0.001 |
Neurological Disorder |
597 (14.8) |
397 (9.3) |
< 0.001** |
770 (22.8) |
224 (4.5) |
< 0.001** |
516 (15.1) |
136 (9.3) |
83 (13.5) |
259 (9.1) |
< 0.001 |
Paralysis |
82 (2.0) |
50 (1.2) |
< 0.001** |
86 (2.6) |
46 (0.9) |
< 0.001** |
63 (1.8) |
26 (1.8) |
7 (1.1) |
36 (1.3) |
0.22 |
Psychoses |
87 (2.2) |
72 (1.7) |
0.11 |
99 (2.9) |
60 (1.2) |
< 0.001 |
88 (2.6) |
31 (2.1) |
8 (1.3) |
32 (1.1) |
< 0.001 |
PUD |
56 (1.4) |
35 (0.8) |
0.013 |
54 (1.6) |
37 (0.7) |
< 0.001** |
43 (1.3) |
17 (1.2) |
4 (0.6) |
27 (1.0) |
0.46 |
Pulmonary Disorders |
326 (8.1) |
211 (4.9) |
< 0.001** |
381 (11.3) |
156 (3.2) |
< 0.001** |
241 (7.0) |
95 (6.5) |
52 (8.4) |
149 (5.3) |
0.005 |
PV Disorders |
367 (9.1) |
217 (5.1) |
< 0.001** |
481 (14.3) |
103 (2.1) |
< 0.001** |
310 (9.1) |
108 (7.4) |
27 (4.4) |
139 (4.9) |
< 0.001 |
Renal Disease |
733 (18.2) |
458 (10.7) |
0.18** |
940 (27.9) |
251 (5.1) |
< 0.001** |
535 (15.6) |
264 (18.1) |
75 (12.2) |
317 (11.2) |
< 0.001 |
Renal Failure |
669 (16.6) |
420 (9.8) |
< 0.001** |
870 (25.8) |
219 (4.4) |
< 0.001** |
491 (14.4) |
238 (16.4) |
67 (10.9) |
293 (10.3) |
< 0.001 |
Rheumatic Disease |
48 (1.2) |
147 (3.4) |
< 0.001* |
119 (3.5) |
76 (1.5) |
< 0.001 |
77 (2.3) |
52 (3.6) |
11 (1.8) |
55 (1.9) |
0.006 |
Smoking |
171 (4.2) |
98 (2.3) |
< 0.001 |
100 (3.0) |
169 (3.4) |
0.063 |
110 (3.8) |
62 (5.4) |
12 (2.8) |
85 (4.2) |
0.058 |
Valvular Heart Disease |
423 (10.5) |
337 (7.9) |
< 0.001 |
614 (18.2) |
146 (2.9) |
< 0.001** |
411 (12.0) |
102 (7.0) |
60 (9.7) |
187 (6.6) |
< 0.001 |
Abbreviations: HIV/AIDS: Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome; CHF: Congestive Heart Failure; CPD: Chronic Pulmonary Disease; CPD: Chronic Pulmonary Disease; HLD: Hyperlipidemia; HTN: Hypertension; PUD: Peptic Ulcer Disease; PV: Peripheral Vascular.
*indicates comorbidities with a demographic modification significant at p-value < 0.10 for mortality risk; **indicates comorbidities with a demographic modification significant at p-value < 0.05 for mortality risk.